Sign in

CIK 0000842023 · Large accelerated filer

BIO-TECHNE Corp

Sign in to watch
Ticker
TECH
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Jun 30
Incorporated
MN
Entity type
operating
EIN
411427402
Phone
612-379-8854
Business address
614 MCKINLEY PLACE NE, MINNEAPOLIS, MN
Former names
TECHNE CORP /MN/
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2018-08-08 Hippel James Chief Financial Officer Grant or award · Restricted Stock Units +3,383 3,383
2018-08-08 Hippel James Chief Financial Officer Grant or award · Stock Options (Right to buy) +24,089 24,089
2018-08-08 Hippel James Chief Financial Officer Grant or award · Stock Options (Right to buy) +18,066 18,066
2018-08-07 Kummeth Charles R. Chief Executive Officer Option exercise +13,816 90,288
2018-08-07 Kummeth Charles R. Chief Executive Officer Shares withheld for taxes −6,301 $180.14 $1.1M 83,987
2018-08-07 Kummeth Charles R. Chief Executive Officer Shares withheld for taxes −1,752 $180.14 $316K 82,235
2018-08-07 Kummeth Charles R. Chief Executive Officer Option exercise · Restricted Stock Units −13,816 3,467
2018-08-07 Kummeth Charles R. Chief Executive Officer Returned to the company · Restricted Stock Units −3,467 0
2018-08-07 Kummeth Charles R. Chief Executive Officer Returned to the company · Stock Options (Right to buy) −23,929 95,346
2018-08-07 Eansor Norman David SVP - Novus Biologicals Option exercise +1,199 3,465
2018-08-07 Eansor Norman David SVP - Novus Biologicals Shares withheld for taxes −348 $180.14 $63K 3,117
2018-08-07 Eansor Norman David SVP - Novus Biologicals Option exercise · Restricted Stock Units −1,199 301
2018-08-07 Eansor Norman David SVP - Novus Biologicals Returned to the company · Restricted Stock Units −301 0
2018-08-07 Eansor Norman David SVP - Novus Biologicals Returned to the company · Stock Options (Right to buy) −1,881 7,494
2018-08-07 Furlow Brenda S. SVP - General Counsel Option exercise +959 2,627
2018-08-07 Furlow Brenda S. SVP - General Counsel Shares withheld for taxes −438 $180.14 $79K 2,189
2018-08-07 Furlow Brenda S. SVP - General Counsel Option exercise · Restricted Stock Units −959 241
2018-08-07 Furlow Brenda S. SVP - General Counsel Returned to the company · Restricted Stock Units −241 0
2018-08-07 Furlow Brenda S. SVP - General Counsel Returned to the company · Stock Options (Right to buy) −1,505 5,995
2018-08-07 Hippel James Chief Financial Officer Option exercise +2,398 5,477

Page 55 of 64 · 1,274 trades